Henderson, D C <br/><br/>
Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study.  [electronic resource] 

 -  The American journal of psychiatry  Jun 2000 
 - 975-81 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0002-953X 
<br/><br/><label>Standard No.: </label>10.1176/appi.ajp.157.6.975  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Age Factors<br/>Antipsychotic Agents--adverse effects<br/>Body Mass Index<br/>Body Weight--drug effects<br/>Cholesterol--blood<br/>Clozapine--adverse effects<br/>Diabetes Mellitus--chemically induced<br/>Diabetes Mellitus, Type 2--chemically induced<br/>Dose-Response Relationship, Drug<br/>Family<br/>Female<br/>Genetic Predisposition to Disease<br/>Humans<br/>Hypercholesterolemia--chemically induced<br/>Hypertriglyceridemia--chemically induced<br/>Incidence<br/>Male<br/>Obesity--chemically induced<br/>Psychotic Disorders--drug therapy<br/>Risk Factors<br/>Schizophrenia--drug therapy<br/>Triglycerides--blood<br/>Valproic Acid--therapeutic use